Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

33.92
-0.3619-1.06%
Post-market: 33.950.0327+0.10%16:10 EDT
Volume:6K
Turnover:198.03K
Market Cap:32.22M
PE:- -
High:33.97
Open:33.93
Low:33.84
Close:34.28
52wk High:36.72
52wk Low:25.59
Shares:950.00K
Float Shares:950.00K
Volume Ratio:0.88
T/O Rate:0.61%
Dividend:0.16
Dividend Rate:0.47%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Reuters
·
Sep 09

Steris PLC Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Sep 09

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

UnitedHealth to Present Strategy at Wells Fargo Conference

TIPRANKS
·
Sep 09

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Abbott Laboratories Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Reuters
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS
·
Sep 09

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

TIPRANKS
·
Sep 09

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

TradingKey
·
Sep 09

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS
·
Sep 09

Resmed Inc Stock (RMD) Moved Down by 3.15% on Sep 8: What Investors Need To Know

TradingKey
·
Sep 09

Option traders moderately bearish in UnitedHealth with shares down 1.28%

TIPRANKS
·
Sep 08

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026

Reuters
·
Sep 08

Abbott Wins FDA Approval for TactiFlex Duo Dual-Energy AFib Ablation Catheter

Reuters
·
Sep 08